Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Jazz Pharmaceuticals ROA 2010-2023 | JAZZ

Current and historical return on assets (ROA) values for Jazz Pharmaceuticals (JAZZ) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
  
Jazz Pharmaceuticals ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2023-12-31 $0.44B $11.39B 3.91%
2023-09-30 $0.08B $11.20B 0.71%
2023-06-30 $-0.09B $11.26B -0.81%
2023-03-31 $-0.16B $11.05B -1.44%
2022-12-31 $-0.22B $10.84B -2.03%
2022-09-30 $-0.02B $10.39B -0.16%
2022-06-30 $-0.05B $11.20B -0.43%
2022-03-31 $-0.45B $11.77B -3.61%
2021-12-31 $-0.33B $12.30B -2.94%
2021-09-30 $-0.16B $12.48B -1.65%
2021-06-30 $0.04B $13.21B 0.49%
2021-03-31 $0.52B $6.76B 8.08%
2020-12-31 $0.24B $6.54B 3.95%
2020-09-30 $0.18B $6.29B 3.10%
2020-06-30 $0.13B $6.07B 2.38%
2020-03-31 $0.28B $5.22B 5.14%
2019-12-31 $0.52B $5.54B 9.58%
2019-09-30 $0.61B $5.53B 11.31%
2019-06-30 $0.66B $5.49B 12.21%
2019-03-31 $0.49B $5.28B 9.10%
2018-12-31 $0.45B $5.20B 8.37%
2018-09-30 $0.52B $5.49B 9.77%
2018-06-30 $0.43B $5.35B 8.36%
2018-03-31 $0.45B $5.29B 8.87%
2017-12-31 $0.49B $5.12B 9.91%
2017-09-30 $0.37B $5.00B 7.70%
2017-06-30 $0.40B $4.80B 8.27%
2017-03-31 $0.41B $4.82B 9.09%
2016-12-31 $0.40B $4.80B 9.52%
2016-09-30 $0.36B $4.93B 9.55%
2016-06-30 $0.36B $3.45B 10.51%
2016-03-31 $0.34B $3.54B 9.76%
2015-12-31 $0.33B $3.33B 9.83%
2015-09-30 $0.33B $3.46B 9.80%
2015-06-30 $0.27B $3.39B 8.02%
2015-03-31 $0.22B $3.24B 6.82%
2014-12-31 $0.06B $3.34B 1.81%
2014-09-30 $0.03B $3.35B 1.07%
2014-06-30 $0.08B $3.16B 3.01%
2014-03-31 $0.08B $3.20B 3.25%
2013-12-31 $0.22B $2.24B 10.09%
2013-09-30 $0.36B $2.19B 17.49%
2013-06-30 $0.32B $2.09B 16.37%
2013-03-31 $0.30B $2.01B 16.43%
2012-12-31 $0.29B $1.97B 18.39%
2012-09-30 $0.13B $1.73B 10.93%
2012-06-30 $0.12B $1.70B 16.24%
2012-03-31 $0.13B $0.90B 33.55%
2011-12-31 $0.12B $0.25B 61.31%
2011-09-30 $0.11B $0.21B 64.25%
2011-06-30 $0.09B $0.19B 62.27%
2011-03-31 $0.05B $0.15B 42.83%
2010-12-31 $0.03B $0.14B 28.57%
2010-09-30 $0.01B $0.11B 13.37%
2010-06-30 $-0.00B $0.10B -0.97%
2010-03-31 $0.01B $0.11B 6.59%
2009-12-31 $-0.01B $0.11B -6.54%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.909B $3.834B
Jazz Pharmaceuticals is a specialty biopharmaceutical company with a focus in the areas of neuroscience & oncology. It derives the majority of its revenues from its sleep disorder drugs' Xywav & Xyrem. Both drugs are approved for treating cataplexy & excessive daytime sleepiness in narcolepsy patients. Other drugs in the company's neuroscience portfolio include' Sunosi, Epidiolex & Sativex. Epidiolex is approved for treating seizures associated with two rare & severe forms of epilepsy' Lennox-Gastaut syndrome & Dravet syndrome. Sativex is approved in the U.K. & Canada as a treatment for symptom improvement in adult patients with moderate-to-severe spasticity due to multiple sclerosis. Jazz's oncology portfolio includes two drugs' Defitelio for the treatment hepatic veno-occlusive disease with renal or pulmonary dysfunction following hematopoietic stem cell transplantation & Vyxeos for the treatment of adults with two types of acute myeloid leukemia. It received approval for two new drugs' Zepzelca & Rylaze'.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $68.403B 28.11
Chugai Pharmaceutical (CHGCY) Japan $55.239B 23.99
Takeda Pharmaceutical (TAK) Japan $42.345B 6.86
Merck (MKGAF) Germany $20.744B 19.57
Astellas Pharma (ALPMY) Japan $17.174B 24.33
Shionogi (SGIOY) Japan $14.546B 12.59
Sandoz Group AG (SDZNY) Switzerland $14.473B 0.00
Neurocrine Biosciences (NBIX) United States $13.940B 57.89
United Therapeutics (UTHR) United States $11.034B 11.82
Catalent (CTLT) United States $10.140B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.624B 0.00
Ionis Pharmaceuticals (IONS) United States $6.098B 0.00
Revolution Medicines (RVMD) United States $5.972B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.345B 0.00
Alpine Immune Sciences (ALPN) United States $4.231B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.078B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.946B 0.00
Evotec AG (EVO) Germany $2.711B 0.00
Summit Therapeutics (SMMT) United States $2.617B 0.00
Indivior (INDV) United States $2.569B 11.94
Corcept Therapeutics (CORT) United States $2.394B 24.21
Dyne Therapeutics (DYN) United States $2.192B 0.00
PTC Therapeutics (PTCT) United States $1.947B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.915B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.818B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.807B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.738B 17.96
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.658B 9.82
Avadel Pharmaceuticals (AVDL) Ireland $1.639B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.587B 27.78
Ardelyx (ARDX) United States $1.487B 0.00
Soleno Therapeutics (SLNO) United States $1.341B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.301B 12.22
4D Molecular Therapeutics (FDMT) United States $1.269B 0.00
Pacira BioSciences (PCRX) United States $1.247B 12.41
Collegium Pharmaceutical (COLL) United States $1.175B 7.23
Xencor (XNCR) United States $1.123B 0.00
Cronos Group (CRON) Canada $0.944B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.943B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.903B 0.00
Cassava Sciences (SAVA) United States $0.889B 0.00
USANA Health Sciences (USNA) United States $0.861B 13.56
ARS Pharmaceuticals (SPRY) United States $0.820B 0.00
Enliven Therapeutics (ELVN) United States $0.813B 0.00
Sage Therapeutics (SAGE) United States $0.778B 0.00
Relay Therapeutics (RLAY) United States $0.774B 0.00
Ocular Therapeutix (OCUL) United States $0.774B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.736B 0.00
Silence Therapeutics (SLN) United Kingdom $0.674B 0.00
Savara (SVRA) United States $0.648B 0.00
Siga Technologies (SIGA) United States $0.623B 9.22
Lyell Immunopharma (LYEL) United States $0.622B 0.00
ProKidney (PROK) United States $0.580B 0.00
Verve Therapeutics (VERV) United States $0.575B 0.00
Korro Bio (KRRO) United States $0.545B 0.00
OmniAb (OABI) United States $0.543B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.542B 0.00
Altimmune (ALT) United States $0.537B 0.00
Exscientia (EXAI) United Kingdom $0.529B 0.00
KalVista Pharmaceuticals (KALV) United States $0.473B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.448B 0.00
Heron Therapeutics (HRTX) United States $0.421B 0.00
Larimar Therapeutics (LRMR) United States $0.412B 0.00
Lexeo Therapeutics (LXEO) United States $0.400B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.397B 0.00
Esperion Therapeutics (ESPR) United States $0.396B 0.00
Organogenesis (ORGO) United States $0.393B 74.50
Tourmaline Bio (TRML) United States $0.387B 0.00
Nature's Sunshine Products (NATR) United States $0.372B 20.81
Harrow (HROW) United States $0.365B 0.00
Bioventus (BVS) United States $0.341B 0.00
Aquestive Therapeutics (AQST) United States $0.314B 0.00
Fractyl Health (GUTS) United States $0.314B 0.00
Lyra Therapeutics (LYRA) United States $0.311B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.291B 0.00
Akebia Therapeutics (AKBA) United States $0.287B 0.00
ESSA Pharma (EPIX) Canada $0.283B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.278B 0.00
Nanobiotix S.A (NBTX) France $0.269B 0.00
Metagenomi (MGX) United States $0.263B 0.00
Pyxis Oncology (PYXS) United States $0.262B 0.00
Nektar Therapeutics (NKTR) United States $0.261B 0.00
Black Diamond Therapeutics (BDTX) United States $0.259B 0.00
Adherex Technologies (FENC) United States $0.250B 0.00
Xeris Biopharma Holdings (XERS) United States $0.250B 0.00
Aldeyra Therapeutics (ALDX) United States $0.232B 0.00
Avita Medical (RCEL) United States $0.231B 0.00
Conduit Pharmaceuticals (CDT) United States $0.229B 0.00
Acrivon Therapeutics (ACRV) United States $0.222B 0.00
Foghorn Therapeutics (FHTX) United States $0.220B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Prelude Therapeutics (PRLD) United States $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
Century Therapeutics (IPSC) United States $0.203B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.200B 0.00
Zevra Therapeutics (ZVRA) United States $0.199B 0.00
Profound Medical (PROF) Canada $0.188B 0.00
Telomir Pharmaceuticals (TELO) United States $0.172B 0.00
MediWound (MDWD) Israel $0.156B 0.00
Achieve Life Sciences (ACHV) Canada $0.154B 0.00
CytoDyn (CYDY) United States $0.149B 0.00
Regulus Therapeutics (RGLS) United States $0.148B 0.00
Incannex Healthcare (IXHL) Australia $0.145B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.132B 2.79
VAXART, INC (VXRT) United States $0.132B 0.00
Elite Pharmaceuticals (ELTP) United States $0.132B 12.32
Karyopharm Therapeutics (KPTI) United States $0.127B 0.00
Cardiol Therapeutics (CRDL) Canada $0.126B 0.00
Inotiv (NOTV) United States $0.125B 0.00
Citius Pharmaceuticals (CTXR) United States $0.122B 0.00
GlycoMimetics (GLYC) United States $0.118B 0.00
Relmada Therapeutics (RLMD) United States $0.118B 0.00
OptiNose (OPTN) United States $0.109B 0.00
FibroGen (FGEN) United States $0.106B 0.00
Eliem Therapeutics (ELYM) United States $0.104B 0.00
Vivani Medical (VANI) United States $0.099B 0.00
ProPhase Labs (PRPH) United States $0.093B 0.00
PMV Pharmaceuticals (PMVP) United States $0.093B 0.00
AlloVir (ALVR) United States $0.091B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
Assertio Holdings (ASRT) United States $0.087B 7.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.085B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.079B 0.00
Tempest Therapeutics (TPST) United States $0.076B 0.00
Carisma Therapeutics (CARM) United States $0.071B 0.00
Journey Medical (DERM) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Mural Oncology (MURA) Ireland $0.062B 0.00
SCYNEXIS (SCYX) United States $0.059B 0.87
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.055B 0.00
BioLineRx (BLRX) Israel $0.051B 0.00
Jaguar Animal Health (JAGX) United States $0.046B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.039B 0.00
JanOne (JAN) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.039B 0.00
Unicycive Therapeutics (UNCY) United States $0.037B 0.00
Protara Therapeutics (TARA) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
CASI Pharmaceuticals (CASI) China $0.034B 0.00
Viracta Therapeutics (VIRX) United States $0.033B 0.00
VYNE Therapeutics (VYNE) United States $0.033B 0.00
NRx Pharmaceuticals (NRXP) United States $0.030B 0.00
Surrozen (SRZN) United States $0.029B 0.00
Nutriband (NTRB) United States $0.028B 0.00
DURECT (DRRX) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Oncternal Therapeutics (ONCT) United States $0.024B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.93
MEI Pharma (MEIP) United States $0.022B 1.12
TherapeuticsMD (TXMD) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
Indaptus Therapeutics (INDP) United States $0.021B 0.00
CERo Therapeutics Holdings (CERO) United States $0.020B 0.00
Addex Therapeutics (ADXN) Switzerland $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Alaunos Therapeutics (TCRT) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Talphera (TLPH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Traws Pharma (TRAW) United States $0.014B 0.00
Avalo Therapeutics (AVTX) United States $0.013B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Cosmos Health (COSM) Greece $0.009B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.29
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 43.90